Prognostic factors and overall survival of breast cancer in Benin: a hospital-based study.
Benin
Breast cancer
Prognostic factors
Sub-saharan africa
Survival
Journal
BMC women's health
ISSN: 1472-6874
Titre abrégé: BMC Womens Health
Pays: England
ID NLM: 101088690
Informations de publication
Date de publication:
18 May 2024
18 May 2024
Historique:
received:
08
07
2023
accepted:
24
04
2024
medline:
19
5
2024
pubmed:
19
5
2024
entrez:
18
5
2024
Statut:
epublish
Résumé
In Benin, a country in West Africa, breast cancer is the leading cancer in women, both in terms of incidence and mortality. However, evidence on the mortality of breast cancer and its associated factors is lacking in this country. Our aim was to describe and analyze the clinical, histopathological, and prognostic aspects of breast cancer in Benin. A descriptive and analytical study was carried out at the CNHU-HKM and the CHU-MEL, two major tertiary referral hospitals for breast cancer management located in Cotonou, the capital city of Benin. All breast cancer medical records with histological evidence and immunohistochemistry studies were retrospectively collected between January 1, 2014, and September 30, 2020, in these two tertiary referral hospitals and analyzed in the current study. Finally, 319 medical records were included. The mean age at diagnosis was 48.74 years. The tumors were most frequently classified as T4 (47.6%) with lymph node involvement N2 (34.5%), and metastases were clinically noted in 21.9% of cases. Stage was reported in the medical records of 284 patients. Tumors were diagnosed at very late AJCC stages: stage III (47.5%) and stage IV (24.7%). Grades SBR 2 (49.2%) and SBR 3 (32.6%) were the most frequent grades. Triple-negative breast cancer (31.3%) was the most common molecular type. The overall 5-year survival was 48.49%. In multivariable analysis, the poor prognostic factors were lymph node invasion (HR = 2.63; p = 0.026; CI: [1.12, 6.17]), the presence of metastasis (HR = 3.64; p < 0.001); CI: [2.36, 5.62] and the immunohistochemical profile (HR = 1.29; p < 0.001; CI: [1.13, 1.48]). Breast cancer in Beninese is predominant in young adults and is often diagnosed at a late stage. The survival of breast cancer patients in Benin can be improved by enhancing early diagnosis and multidisciplinary management.
Sections du résumé
BACKGROUND
BACKGROUND
In Benin, a country in West Africa, breast cancer is the leading cancer in women, both in terms of incidence and mortality. However, evidence on the mortality of breast cancer and its associated factors is lacking in this country. Our aim was to describe and analyze the clinical, histopathological, and prognostic aspects of breast cancer in Benin.
METHODS
METHODS
A descriptive and analytical study was carried out at the CNHU-HKM and the CHU-MEL, two major tertiary referral hospitals for breast cancer management located in Cotonou, the capital city of Benin. All breast cancer medical records with histological evidence and immunohistochemistry studies were retrospectively collected between January 1, 2014, and September 30, 2020, in these two tertiary referral hospitals and analyzed in the current study.
RESULTS
RESULTS
Finally, 319 medical records were included. The mean age at diagnosis was 48.74 years. The tumors were most frequently classified as T4 (47.6%) with lymph node involvement N2 (34.5%), and metastases were clinically noted in 21.9% of cases. Stage was reported in the medical records of 284 patients. Tumors were diagnosed at very late AJCC stages: stage III (47.5%) and stage IV (24.7%). Grades SBR 2 (49.2%) and SBR 3 (32.6%) were the most frequent grades. Triple-negative breast cancer (31.3%) was the most common molecular type. The overall 5-year survival was 48.49%. In multivariable analysis, the poor prognostic factors were lymph node invasion (HR = 2.63; p = 0.026; CI: [1.12, 6.17]), the presence of metastasis (HR = 3.64; p < 0.001); CI: [2.36, 5.62] and the immunohistochemical profile (HR = 1.29; p < 0.001; CI: [1.13, 1.48]).
CONCLUSIONS
CONCLUSIONS
Breast cancer in Beninese is predominant in young adults and is often diagnosed at a late stage. The survival of breast cancer patients in Benin can be improved by enhancing early diagnosis and multidisciplinary management.
Identifiants
pubmed: 38762733
doi: 10.1186/s12905-024-03114-y
pii: 10.1186/s12905-024-03114-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
295Informations de copyright
© 2024. The Author(s).
Références
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin Mai. 2021;71(3):209–49.
doi: 10.3322/caac.21660
Joko-Fru WY, Griesel M, Mezger NCS, Hämmerl L, Seraphin TP, Feuchtner J et al. Breast Cancer Diagnostics, Therapy, and Outcomes in Sub-Saharan Africa: A Population-Based Registry Study. J Natl Compr Cancer Netw JNCCN. 29 déc. 2021;1–11.
Bray F, Parkin DM, Gnangnon F, Tshisimogo G, Peko JF, Adoubi I, et al. Cancer in sub-saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs. Lancet Oncol 1 juin. 2022;23(6):719–28.
doi: 10.1016/S1470-2045(22)00270-4
Salami L, Ouendo EM, Fayomi B. Qualité Du système D’information et de suivi des interventions en santé dans les zones exposées Au Financement basé sur les résultats en 2014 Au Bénin. Pan Afr Med J 22 Nov. 2017;28:257.
Jalan D, Rubagumya F, Hopman WM, Vanderpuye V, Lopes G, Seruga B, et al. Training of oncologists: results of a global survey. Ecancermedicalscience 17 Juill. 2020;14:1074.
Soerjomataram I, Cabasag C, Bardot A, Fidler-Benaoudia MM, Miranda-Filho A, Ferlay J, et al. Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries. Lancet Oncol 1 janv. 2023;24(1):22–32.
doi: 10.1016/S1470-2045(22)00704-5
Joko-Fru WY, Miranda-Filho A, Soerjomataram I, Egue M, Akele-Akpo MT, N’da G, et al. Breast cancer survival in sub-saharan Africa by age, stage at diagnosis and human development index: a population-based registry study. Int J Cancer 1 mars. 2020;146(5):1208–18.
doi: 10.1002/ijc.32406
Tetteh DA, Faulkner SL. Sociocultural factors and breast cancer in sub-saharan Africa: implications for diagnosis and management. Womens Health Lond Engl janv. 2016;12(1):147–56.
doi: 10.2217/whe.15.76
McCormack V, McKenzie F, Foerster M, Zietsman A, Galukande M, Adisa C, et al. Breast cancer survival and survival gap apportionment in sub-saharan Africa (ABC-DO): a prospective cohort study. Lancet Glob Health. 2020;8(9):e1203–12.
doi: 10.1016/S2214-109X(20)30261-8
pubmed: 32827482
pmcid: 7450275
World Bank. Benin Presentation [Online]. 2023[cited 4 dec 2023]. https://www.banquemondiale.org/fr/country/benin/overview .
Birnbaum Z, Jones G, Diaz G, Duncan T, Romero J, Steen S. Association of socioeconomic status with the clinical management and outcomes in young patients (≤ 35 years) diagnosed with breast cancer: a retrospective analysis. Ann Med Surg 2 sept. 2022;82:104524.
Sørensen JB, Klee M, Palshof T, Hansen HH. Performance status assessment in cancer patients. An inter-observer variability study. Br J Cancer avr. 1993;67(4):773–5.
doi: 10.1038/bjc.1993.140
Compérat E, Varinot J, Eymerit C, Paner GP, Hansel DE, Amin MB, et al. [Comparison of UICC and AJCC 8th Edition TNM classifications in uropathology]. Ann Pathol avr. 2019;39(2):158–66.
doi: 10.1016/j.annpat.2018.12.005
Amat S, Penault-Llorca F, Cure H, Le Bouedëc G, Achard JL, Van Praagh I, et al. Scarff-Bloom-Richardson (SBR) grading: a pleiotropic marker of chemosensitivity in invasive ductal breast carcinomas treated by neoadjuvant chemotherapy. Int J Oncol avr. 2002;20(4):791–6.
Blows FM, Driver KE, Schmidt MK, Broeks A, van Leeuwen FE, Wesseling J et al. may. Subtyping of breast Cancer by immunohistochemistry to investigate a relationship between subtype and Short and long term survival: a collaborative analysis of data for 10,159 cases from 12 Studies.Plos Medicine. 2010;7(5): e1000279.
Grosse Frie K, Kamaté B, Traoré CB, Ly M, Mallé B, Coulibaly B, et al. Factors associated with time to first healthcare visit, diagnosis and treatment, and their impact on survival among breast cancer patients in Mali. PLoS ONE. nov 2018;29(11):e0207928.
Engbang JPN, Essome H, Koh VM, Simo G, Essam JDS, Mouelle AS, et al. Cancer Du Sein Au Cameroun, profil histo-épidémiologique: à propos de 3044 cas. Pan Afr Med J 4 août. 2015;21:242.
Dabakuyo-Yonli S, Arveux P. [Epidemiology of breast cancer]. Rev Prat Sept. 2020;70(7):726–9.
Cowppli-Bony A, Colonna M, Ligier K, Jooste V, Defossez G, Monnereau A, et al. Épidémiologie descriptive des cancers en France métropolitaine: incidence, survie et prévalence. Bull Cancer (Paris) 1 Juill. 2019;106(7):617–34.
doi: 10.1016/j.bulcan.2018.11.016
Hemminki K, Mousavi SM, Sundquist J, Brandt A. Does the breast Cancer age at diagnosis Differ by Ethnicity? A study on immigrants to Sweden. Oncologist févr. 2011;16(2):146–54.
doi: 10.1634/theoncologist.2010-0104
George SHL, Donenberg T, Alexis C, DeGennaro V, Dyer H, Yin S, et al. Gene sequencing for pathogenic variants among adults with breast and ovarian Cancer in the Caribbean. JAMA Netw Open 1 mars. 2021;4(3):e210307.
doi: 10.1001/jamanetworkopen.2021.0307
Orsini M, Trétarre B, Daurès JP, Bessaoud F. Individual socioeconomic status and breast cancer diagnostic stages: a French case-control study. Eur J Public Health juin. 2016;26(3):445–50.
doi: 10.1093/eurpub/ckv233
Lehrer S, Green S, Rosenzweig KE. Affluence and breast Cancer. Breast J sept. 2016;22(5):564–7.
doi: 10.1111/tbj.12630
Krieger N. Is breast Cancer a disease of affluence, poverty, or both? The case of African American women. Am J Public Health avr. 2002;92(4):611–3.
doi: 10.2105/AJPH.92.4.611
Althuis MD, Brogan DD, Coates RJ, Daling JR, Gammon MD, Malone KE, et al. Breast cancers among very young premenopausal women (United States). Cancer Causes Control CCC mars. 2003;14(2):151–60.
doi: 10.1023/A:1023006000760
Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 29 mai. 1997;71(5):800–9.
doi: 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.0.CO;2-B
World Bank Open Data [Online]. 2023.[cited 4 dec 2023]. https://data.worldbank.org .
Tuli S. Reimaginin.g rural cancer care - the Butaro Cancer Center of Excellence (BCCOE) in Rwanda. Rural Remote Health janv. 2023;23(1):8174.
Aloulou S, El Mahfoudi A, El Omrani A, Khouchani M. Facteurs liés Au diagnostic tardif Du cancer Du Sein: expérience Du CHU Mohammed VI Marrakech. Pan Afr Med J 25 juin. 2015;21:162.
Coleman C. Early detection and screening for breast Cancer. Semin Oncol Nurs Mai. 2017;33(2):141–55.
doi: 10.1016/j.soncn.2017.02.009
Lee CH, Dershaw DD, Kopans D, Evans P, Monsees B, Monticciolo D, et al. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol JACR janv. 2010;7(1):18–27.
Jedy-Agba E, McCormack V, Adebamowo C, dos-Santos-Silva I. Stage at diagnosis of breast cancer in sub-saharan Africa: a systematic review and meta-analysis. Lancet Glob Health déc. 2016;4(12):e923–35.
doi: 10.1016/S2214-109X(16)30259-5
Elidrissi Errahhali M, Elidrissi Errahhali M, Ouarzane M, El Harroudi T, Afqir S, Bellaoui M. First report on molecular breast cancer subtypes and their clinico-pathological characteristics in Eastern Morocco: series of 2260 cases. BMC Womens Health 9 janv. 2017;17:3.
doi: 10.1186/s12905-016-0361-z
Dialla PO, Dabakuyo TS, Marilier S, Gentil J, Roignot P, Darut-Jouve A, et al. Population-based study of breast cancer in older women: prognostic factors of relative survival and predictors of treatment. BMC Cancer 15 oct. 2012;12(1):472.
doi: 10.1186/1471-2407-12-472
Allemani C, Sant M, Weir HK, Richardson LC, Baili P, Storm H, et al. Breast cancer survival in the US and Europe: a CONCORD high-resolution study. Int J Cancer 1 mars. 2013;132(5):1170–81.
doi: 10.1002/ijc.27725
Togo A, Traoré A, Traoré C, Dembélé BT, Kanté L, Diakité I, et al. Cancer Du sein dans deux centres hospitaliers de Bamako (Mali): aspects diagnostiques et thérapeutiques. J Afr Cancer Afr J Cancer 1 mai. 2010;2(2):88–91.
doi: 10.1007/s12558-010-0060-x
Fouad A, Yousra A, Kaoutar Z, Omar EM, Afaf A, Sanae B. Classification moléculaire Du cancer Du Sein Au Maroc. Pan Afr Med J 31 déc. 2012;13:91.
Brawley OW, Lansey DG. Disparities in breast Cancer outcomes and how to resolve them. Hematol Oncol Clin North Am 1 févr. 2023;37(1):1–15.
doi: 10.1016/j.hoc.2022.08.002
Howlader N, Cronin KA, Kurian AW, Andridge R. Differences in Breast Cancer Survival by Molecular Subtypes in the United States. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. juin. 2018;27(6):619–26.
Der EM, Gyasi RK, Tettey Y, Edusei L, Bayor MT, Jiagge E, et al. Triple-negative breast Cancer in Ghanaian women: the Korle Bu Teaching Hospital Experience. Breast J déc. 2015;21(6):627–33.
doi: 10.1111/tbj.12527
Proctor E, Kidwell KM, Jiagge E, Bensenhaver J, Awuah B, Gyan K, et al. Characterizing breast Cancer in a Population with increased prevalence of Triple-negative breast Cancer: androgen receptor and ALDH1 expression in Ghanaian Women. Ann Surg Oncol Nov. 2015;22(12):3831–5.
doi: 10.1245/s10434-015-4455-x
Plasilova ML, Hayse B, Killelea BK, Horowitz NR, Chagpar AB, Lannin DR. Features of triple-negative breast cancer: analysis of 38,813 cases from the national cancer database. Med (Baltimore) août. 2016;95(35):e4614.
doi: 10.1097/MD.0000000000004614
Dietze EC, Sistrunk C, Miranda-Carboni G, O’regan R, Seewaldt VL. Triple-negative breast cancer in African-American women: disparities versus biology. Nat Rev Cancer. 2015;15(4):248–54.
doi: 10.1038/nrc3896
pubmed: 25673085
pmcid: 5470637
Amoussou-Guenou KM, Fachinan OH, Gbénou S, Komongui D, Houndétoungan GD. Place De La Scintigraphie et de la radiothérapie dans les évacuations sanitaires hors du Bénin De 2006 à 2010. Médecine Nucl 1 oct. 2013;37:507–10.
doi: 10.1016/j.mednuc.2013.09.009
Tonato Bagnan JA, Denakpo JL, Aguida B, Hounkpatin L, Lokossou A, De Souza J, et al. Épidémiologie Des cancers gynécologiques et mammaires à l’hôpital de la Mère et de l’enfant-lagune (HOMEL) Et à La Clinique universitaire de gynécologie et d’obstétrique (CUGO) de Cotonou, Bénin. Bull Cancer (Paris) 1 févr. 2013;100(2):141–6.
doi: 10.1684/bdc.2013.1702
Quinn MJ, Cooper N, Rachet B, Mitry E, Coleman MP. Survival from cancer of the breast in women in England and Wales up to 2001. Br J Cancer Sept. 2008;99(1):S53–5.
doi: 10.1038/sj.bjc.6604587
World Health OrganiZation. Global Breast Cancer Initiative Implementation Framework Assessing, strengthening and scaling up services for the early detection and management of breast cancer. 2023.